The Enterprise Value as of September 2024 (TTM) for Aurinia Pharmaceuticals Inc. (AUPH) is 1.09B

According to Aurinia Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.09B. This represents a change of 5.39% compared to the average of 1.03B of the last 4 quarters.

Aurinia Pharmaceuticals Inc. (AUPH) Historical Enterprise Value (quarterly & annually)

How has AUPH Enterprise Value performed in the past?

The mean historical Enterprise Value of Aurinia Pharmaceuticals Inc. over the last ten years is 841.07M. The current 1.09B Enterprise Value has changed 12.87% with respect to the historical average. Over the past ten years (40 quarters), AUPH's Enterprise Value was at its highest in in the September 2021 quarter at 2.79B. The Enterprise Value was at its lowest in in the December 2015 quarter at 73.99M.

Aurinia Pharmaceuticals Inc. (AUPH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aurinia Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aurinia Pharmaceuticals Inc. (AUPH) Average Enterprise Value

How has AUPH Enterprise Value performed in the past?

The current Enterprise Value of Aurinia Pharmaceuticals Inc. (AUPH) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Aurinia Pharmaceuticals Inc. (AUPH) Enterprise Value vs. Peers

How is AUPH’s Enterprise Value compared to its peers?

Aurinia Pharmaceuticals Inc.’s Enterprise Value is less than Viking Therapeutics, Inc. (5.95B), less than Axsome Therapeutics, Inc. (4.35B), less than Madrigal Pharmaceuticals, Inc. (4.91B), less than ImmunoGen, Inc. (8.19B), greater than Seres Therapeutics, Inc. (286.75M), less than Exelixis, Inc. (7.21B), less than TG Therapeutics, Inc. (3.44B), greater than BioXcel Therapeutics, Inc. (69.61M), less than Sarepta Therapeutics, Inc. (13.28B), greater than Hepion Pharmaceuticals, Inc. (2.24M), less than PTC Therapeutics, Inc. (2.17B), less than Intercept Pharmaceuticals, Inc. (0), greater than Terns Pharmaceuticals, Inc. (915.81M), greater than Akero Therapeutics, Inc. (458.36M), less than Reata Pharmaceuticals, Inc. (1.56B), less than null (6.68B),

Build a custom stock screener for Aurinia Pharmaceuticals Inc. (AUPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aurinia Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aurinia Pharmaceuticals Inc. (AUPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aurinia Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.